Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

'Impossible to give consent': Medtech giant hid bad data from patients, doctors

6 September 2026 · By · Wire by Fusion42

Published

6 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Australia

◆ Source

Read at smh.com.au →

◆ Verified

Fusion42 · 6 September 2026 · Fusion42 review

Australia's medical regulator alleges Medtronic deliberately concealed poor real-world data on its Intellis spinal cord stimulator, challenging claims about its effectiveness and raising concerns about informed patient consent and regulatory gaps.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You face a tougher compliance environment as Medtronic’s concealment exposes regulatory blind spots in medtech approvals. You must rethink data transparency immediately to avoid reputational and legal risks.

◆ Coverage

1 source · 6 Sep 2026

◆ Related on Wire

◆ Topics

Medtechmedtronicspinal-cord-stimulatorregulatory-complaintspatient-safetyclinical-trials